Semantic Scholar uses AI to extract papers important to this topic.
The cytokine interleukin‐31 (IL‐31) is considered to be responsible for the development of pruritus in humans. At present, no… Expand BackgroundMany clinicians have concerns about the safety of atopic dermatitis (AD) treatments, particularly in children requiring… Expand This study was conducted to develop formulations of hydrocortisone butyrate (HB)-loaded poly(d,l-lactic-co-glycolic acid… Expand
Background The treatment of vitiligo remains unsatisfactory.
Background Vitiligo is a pigmentary disorder which may have disfiguring consequences. Its treatment remains a challenge.
Background Staphylococcus aureus has a peculiar ability to colonize the skin of patients with eczema and atopic dermatitis (AD… Expand Background Atopic dermatis (AD) is a chronic disease that often requires long‐term treatment. Topical corticosteroids are the… Expand Abstract Objective To determine the efficacy and tolerability of topical pimecrolimus and tacrolimus compared with other… Expand Summary Background Fexofenadine, a nonsedating, H1‐receptor selective antihistamine, exhibits consistent efficacy and safety in… Expand BACKGROUND
Vehicle-controlled studies have demonstrated the efficacy and safety of tacrolimus ointment for patients with atopic… Expand